Urasaki Y - Search Results

1

Human apurinic/apyrimidinic endonuclease (Ape1) and its N-terminal truncated form (AN34) are involved in DNA fragmentation during apoptosis.

Yoshida A, Urasaki Y, Waltham M, Bergman AC, Pourquier P, Rothwell DG, Inuzuka M, Weinstein JN, Ueda T, Appella E, Hickson ID, Pommier Y. Yoshida A, et al. Among authors: urasaki y. J Biol Chem. 2003 Sep 26;278(39):37768-76. doi: 10.1074/jbc.M304914200. Epub 2003 Jul 3. J Biol Chem. 2003. PMID: 12842873 Free article.

2

Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals.

Sordet O, Khan QA, Plo I, Pourquier P, Urasaki Y, Yoshida A, Antony S, Kohlhagen G, Solary E, Saparbaev M, Laval J, Pommier Y. Sordet O, et al. Among authors: urasaki y. J Biol Chem. 2004 Nov 26;279(48):50499-504. doi: 10.1074/jbc.M410277200. Epub 2004 Sep 22. J Biol Chem. 2004. PMID: 15448130 Free article.

3

Topoisomerase I inhibitors: selectivity and cellular resistance.

Pommier Y, Pourquier P, Urasaki Y, Wu J, Laco GS. Pommier Y, et al. Among authors: urasaki y. Drug Resist Updat. 1999 Oct;2(5):307-318. doi: 10.1054/drup.1999.0102. Drug Resist Updat. 1999. PMID: 11504505

4

Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I.

Pourquier P, Gioffre C, Kohlhagen G, Urasaki Y, Goldwasser F, Hertel LW, Yu S, Pon RT, Gmeiner WH, Pommier Y. Pourquier P, et al. Among authors: urasaki y. Clin Cancer Res. 2002 Aug;8(8):2499-504. Clin Cancer Res. 2002. PMID: 12171875

5

Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.

Reinhold WC, Kouros-Mehr H, Kohn KW, Maunakea AK, Lababidi S, Roschke A, Stover K, Alexander J, Pantazis P, Miller L, Liu E, Kirsch IR, Urasaki Y, Pommier Y, Weinstein JN. Reinhold WC, et al. Among authors: urasaki y. Cancer Res. 2003 Mar 1;63(5):1000-11. Cancer Res. 2003. PMID: 12615715

6

Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.

Pourquier P, Takebayashi Y, Urasaki Y, Gioffre C, Kohlhagen G, Pommier Y. Pourquier P, et al. Among authors: urasaki y. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1885-90. doi: 10.1073/pnas.97.4.1885. Proc Natl Acad Sci U S A. 2000. PMID: 10677551 Free PMC article.

7

Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations.

Urasaki Y, Takebayashi Y, Pommier Y. Urasaki Y, et al. Cancer Res. 2000 Dec 1;60(23):6577-80. Cancer Res. 2000. PMID: 11118036

8

Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.

Pourquier P, Waltman JL, Urasaki Y, Loktionova NA, Pegg AE, Nitiss JL, Pommier Y. Pourquier P, et al. Among authors: urasaki y. Cancer Res. 2001 Jan 1;61(1):53-8. Cancer Res. 2001. PMID: 11196197

9

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.

Takebayashi Y, Pourquier P, Zimonjic DB, Nakayama K, Emmert S, Ueda T, Urasaki Y, Kanzaki A, Akiyama SI, Popescu N, Kraemer KH, Pommier Y. Takebayashi Y, et al. Among authors: urasaki y. Nat Med. 2001 Aug;7(8):961-6. doi: 10.1038/91008. Nat Med. 2001. PMID: 11479630

10

Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.

Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y. Urasaki Y, et al. Cancer Res. 2001 Mar 1;61(5):1964-9. Cancer Res. 2001. PMID: 11280753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters